IL-4 and IL-13, which are both induced by type 2 immune responses, decrease inflammation in metabolic organs by inducing M2 polarization of macrophages, leading to the improvement of systemic glucose intolerance in mice [50]. Here, IL4 is linked to Glucose intolerance.